NGU AUNG: Open Payments
NPI 1760741961 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,300 in 110 payments from 26 companies in 2025. Trend: 2023 $1,519 · 2024 $2,682 · 2025 $2,300
Food & beverage: $2,272Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $298 |
| Alkermes, Inc. | 13 | $260 |
| Teva Pharmaceuticals USA, Inc. | 11 | $202 |
| Janssen Pharmaceuticals, Inc | 8 | $175 |
| Lundbeck LLC | 9 | $153 |
| UCB, Inc. | 4 | $130 |
| SK Life Science, Inc. | 4 | $126 |
| E.R. Squibb & Sons, L.L.C. | 5 | $116 |
| Alexion Pharmaceuticals, Inc. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $89 |
Products named: ARISTADA, VRAYLAR, SPRAVATO, REXULTI, AUSTEDO XR, COBENFY, VYEPTI, ULTOMIRIS.
Industry payments across NC — which companies pay providers there.
